Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
- Author(s): Cavendish, Jeffrey J
- Cramer, Steven C
- Graham, Glenn D
- et al.
Published Web Locationhttps://doi.org/10.1185/030079904x10674
The etiology of cerebrovascular disease is heterogeneous, with the majority of strokes being of ischemic origin. Transient ischemic attack is now considered to be an important precursor and long-term risk factor for ischemic stroke. Given the lack of acute therapies for ischemic stroke, current treatments focus on secondary prevention through risk-factor management, pharmacotherapy and interventional approaches. As illustrated in this paper, antiplatelet agents (e.g. clopidogrel, aspirin, dipyridamole) are the cornerstone of therapy for prevention of recurrent ischemic stroke.